SCHEMBL14982704

SCHEMBL14982704

CSc1sc2ccc(C)cc2[n+]1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 9/20 0.45
▸ INSR P06213 2/20 0.43
▸ KDM4E B2RXH2 6/20 0.43
▸ ALDH1A1 P00352 5/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ THRB P10828 2/20 0.38
▸ RECQL P46063 2/20 0.38
▸ LMNA P02545 1/20 0.37
▸ PARP10 Q53GL7 1/20 0.36
▸ PARP2 Q9UGN5 1/20 0.36
▸ APP P05067 2/20 0.35
▸ SNCA P37840 2/20 0.35
▸ TNF P01375 1/20 0.35
▸ NOD1 Q9Y239 1/20 0.35
▸ POLB P06746 3/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ BCHE P06276 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14434817 0.81 MAPT (0.61) MAPTINSRKDM4EALDH1A1TDP1
SCHEMBL13652086 0.81 INSR (0.45) MAPTINSRKDM4EALDH1A1TDP1
Iodide SCHEMBL31063683 0.79 MAPT (0.64) MAPTINSRKDM4EALDH1A1TDP1
Iodide SCHEMBL9204287 0.79 INSR (0.44) MAPTINSRKDM4EALDH1A1TDP1
SCHEMBL13652085 0.78 MAPT (0.67) MAPTINSRKDM4EALDH1A1TDP1
SCHEMBL4822992 0.77 MAPT (0.48) MAPTINSRKDM4EALDH1A1TDP1
SCHEMBL12302034 0.77 MAPT (0.36) MAPTKDM4EALDH1A1TDP1THRB
SCHEMBL9161806 0.74 MAPT (0.52) MAPTKDM4EALDH1A1TDP1THRB
SCHEMBL9651115 0.73 BCHE (0.39) MAPTKDM4EALDH1A1TDP1THRB
SCHEMBL13052511 0.72 KDM4E (0.35) MAPTKDM4EALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8742114-B2 Nucleic acid detections and methods of their use Ying, Laiqiang (US) 2014-06-03 — — US disclosed
US-20130137875-A1 NUCLEIC ACID DETECTIONS AND METHODS OF THEIR USE Ying, Laiqiang (US) 2013-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137875-A1 NUCLEIC ACID DETECTIONS AND METHODS OF THEIR USE DDB1, DNTT, DNA2 MAPT 3684/4885INSR 2049/4885KDM4E 4421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback